3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Osteosarcoma
2
Neoplasm Metastasis
2
Gliosarcoma
2
Glioblastoma
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Oligodendroglioma
1
Melanoma
1
Lung Neoplasms
1
Glioma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Paclitaxel
7
Specimen Handling
6
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
Biopsy
4
pembrolizumab
3
Taxes
3
Nivolumab
3
Carboplatin
3
trastuzumab deruxtecan
2
olaparib
2
ceralasertib
2
aflibercept
2
X-Rays
2
Psychiatric Rehabilitation
2
Irinotecan
2
Ipilimumab
2
Immunoglobulin G
2
Ifosfamide
2
Gene Expression Profiling
2
Fulvestrant
2
Filgrastim
2
Fentanyl
2
Doxorubicin
2
Bevacizumab
2
trifluridine tipiracil drug combination
1
toripalimab
1
tinostamustine
1
spartalizumab
1
selinexor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
Colony-Stimulating Factors
×
Sarcoma
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled